Literature DB >> 11337054

Hybrid nanogels for sustainable positive thermosensitive drug release.

Y Shin1, J H Chang, J Liu, R Williford, Y Shin1, G J Exarhos.   

Abstract

A hybrid nanogel has been developed based on interpenetrating networks of thermosensitive poly(N-isopropylacrylamide) gels and tailored nanoporous silica. A sustainable positive thermo-responsive drug release profile is obtained. When the temperature rises, the polymer gel shrinks, squeezing the drug into the porous channels, and at the same time, opening the pores to the outside media. The drug slowly diffuses out of the porous channels. The overall release rate can be adjusted by changing the composition of the nanogel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337054     DOI: 10.1016/s0168-3659(01)00247-4

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  5 in total

1.  Navigare necessere est. Improved navigation would help to solve two crucial problems in modern drug therapy: toxicity and precise delivery.

Authors:  Sandra Kraljevic; Kresimir Pavelic
Journal:  EMBO Rep       Date:  2005-08       Impact factor: 8.807

Review 2.  Nanogels as pharmaceutical carriers: finite networks of infinite capabilities.

Authors:  Alexander V Kabanov; Serguei V Vinogradov
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

3.  Peptide-functionalized nanogels for targeted siRNA delivery.

Authors:  William H Blackburn; Erin B Dickerson; Michael H Smith; John F McDonald; L Andrew Lyon
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

4.  Core-Shell Nanoparticles as an Efficient, Sustained, and Triggered Drug-Delivery System.

Authors:  Sonal Deshpande; Sapna Sharma; Veena Koul; Neetu Singh
Journal:  ACS Omega       Date:  2017-10-06

5.  Preparation of poly(NIPAAm)-Pluronic F68 as a thermosensitive surfactant for a controlled drug release.

Authors:  Sung-Wook Choi; Hye Min Lee; Tae-Joon Park; Jung-Hyun Kim
Journal:  Int J Pharm Investig       Date:  2011-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.